MetaVia Total Assets 2015-2024 | MTVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MetaVia total assets from 2015 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MetaVia total assets from 2015 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$148.2B
Vertex Pharmaceuticals (VRTX)	$120.8B
Bristol Myers Squibb (BMY)	$117.9B
Gilead Sciences (GILD)	$115.1B
CSL (CSLLY)	$87.1B
Regeneron Pharmaceuticals (REGN)	$85.5B
GSK (GSK)	$73B
Argenex SE (ARGX)	$36.8B
Alnylam Pharmaceuticals (ALNY)	$32.7B
BioNTech SE (BNTX)	$27.8B
Illumina (ILMN)	$23.6B
Biogen (BIIB)	$22.8B
BeiGene (BGNE)	$18.3B
Moderna (MRNA)	$16B
Genmab (GMAB)	$14.4B
Incyte (INCY)	$14B
Insmed (INSM)	$13B
BioMarin Pharmaceutical (BMRN)	$12.7B
Bio-Techne Corp (TECH)	$12.3B
Sarepta Therapeutics (SRPT)	$12.1B
Exact Sciences (EXAS)	$11.4B
Vaxcyte (PCVX)	$11.3B
QIAGEN (QGEN)	$10.5B
Exelixis (EXEL)	$10.1B
Bio-Rad Laboratories (BIO.B)	$9.4B
Intra-Cellular Therapies (ITCI)	$8.8B
Roivant Sciences (ROIV)	$8.8B
Repligen (RGEN)	$8.5B
Revolution Medicines (RVMD)	$8B
Ascendis Pharma (ASND)	$7.9B